FAH encodes fumarylacetoacetase (fumarylacetoacetate hydrolase, EC 3.7.1.2), the enzyme that catalyzes the fifth and final step of the cytosolic L-tyrosine and L-phenylalanine catabolic pathway: the hydrolysis of 4-fumarylacetoacetate to fumarate plus acetoacetate. It is a homodimer, with each subunit using a bound Ca(2+) and Mg(2+) ion as catalytic cofactors, and is expressed mainly in liver and kidney with lower levels in other tissues. By clearing 4-fumarylacetoacetate, FAH prevents accumulation of this reactive intermediate and the upstream metabolite maleylacetoacetate, feeding fumarate into the citric acid cycle and acetoacetate into ketone-body/lipid metabolism. Loss-of-function variants cause hepatorenal tyrosinemia type I (TYRSN1), the most severe tyrosinemia, in which accumulated fumarylacetoacetate, maleylacetoacetate, and the derived toxin succinylacetone drive hepatocyte apoptosis, cirrhosis, hepatocellular carcinoma risk, and renal tubular dysfunction.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0006572
L-tyrosine catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred involvement of FAH in L-tyrosine catabolism. FAH is the terminal (fifth) enzyme of the tyrosine degradation pathway, and this is a core biological-process annotation.
Reason: FAH catalyzes the last step of tyrosine catabolism, hydrolyzing 4-fumarylacetoacetate to fumarate and acetoacetate; this is well supported experimentally and is the defining role of the gene. The IBA is consistent with the whole FAH family and with the direct human evidence.
Supporting Evidence:
PMID:9305902
HT1 is due to mutations in the fumarylacetoacetate hydrolase gene Fah, encoding the last enzyme in the tyrosine catabolic pathway.
|
|
GO:0004334
fumarylacetoacetase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred fumarylacetoacetase (EC 3.7.1.2) activity. This is the core molecular function of FAH.
Reason: Direct enzymatic activity is documented for human FAH and the term matches the catalyzed reaction exactly (4-fumarylacetoacetate + H2O = acetoacetate + fumarate + H+). The IBA is at the correct level of specificity.
Supporting Evidence:
PMID:1998338
having enzymatic activity as shown by the hydrolysis of the natural substrate fumarylacetoacetate
|
|
GO:0006559
L-phenylalanine catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred involvement in L-phenylalanine catabolism. Phenylalanine is catabolized via conversion to tyrosine, so FAH is the terminal step of both pathways.
Reason: UniProt places FAH as the final step (step 6/6) of L-phenylalanine degradation to acetoacetate and fumarate (UniPathway UPA00139). The annotation is correct, though the phenylalanine framing is one metabolic conversion removed from FAH's direct substrate; the more direct role is captured by L-tyrosine catabolic process.
Supporting Evidence:
PMID:1998338
having enzymatic activity as shown by the hydrolysis of the natural substrate fumarylacetoacetate
|
|
GO:1902000
homogentisate catabolic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetically inferred involvement in homogentisate catabolism. Homogentisate is a tyrosine-pathway intermediate several steps upstream of FAH's substrate.
Reason: FAH acts on 4-fumarylacetoacetate, three enzymatic steps downstream of homogentisate (which is ring-cleaved by HGD to maleylacetoacetate). This IBA reflects a pathway-level grouping propagated across the FAH family rather than a direct role of FAH in homogentisate breakdown. It is not wrong at the whole-pathway level but is broader than FAH's actual biochemical step, so it is retained as non-core.
|
|
GO:0003824
catalytic activity
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: InterPro2GO electronic annotation to the root molecular-function catalytic term.
Reason: GO:0003824 is the top-level catalytic activity term and is uninformative for FAH, whose specific activity (fumarylacetoacetase, GO:0004334) is already annotated with stronger evidence. It is not incorrect, but it is an over-general mapping superseded by the specific EC 3.7.1.2 term.
|
|
GO:0004334
fumarylacetoacetase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation (combined IEA pipeline, keyed to RHEA:10244 / EC 3.7.1.2) to the core fumarylacetoacetase activity term.
Reason: This IEA maps FAH to its correct catalyzed reaction via RHEA:10244 and EC 3.7.1.2, in agreement with the IBA and TAS annotations to the same term. Redundant but correct.
|
|
GO:0009072
aromatic amino acid metabolic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro2GO electronic annotation to the broad aromatic amino acid metabolic process grouping term.
Reason: Tyrosine and phenylalanine are aromatic amino acids, so FAH's catabolic role legitimately falls under this grouping term. However it is more general than the specific tyrosine and phenylalanine catabolic process annotations that better describe FAH, so it is retained as non-core.
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: Bare protein binding from a high-throughput binary interactome (Y2H) screen; interactors include TCF4 and keratin-associated proteins.
Reason: This is an uninformative bare protein binding annotation from a genome-scale binary interactome map (the human interactome network / HuRI project). The reported partners (e.g. TCF4, keratin-associated proteins) have no plausible functional relationship to a cytosolic tyrosine-catabolic hydrolase and are typical high-throughput Y2H hits. Per curation guidelines this bare protein binding conveys no specific molecular function; it is retained but flagged as an over-annotation (not removed, as it is an experimental IPI).
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare protein binding from the HuRI binary reference interactome (Y2H); interactors include ADAMTSL4, CHRDL2, KRTAP13-3, PLEKHF2, SERTAD1.
Reason: As with PMID:25416956, this is an uninformative bare protein binding annotation from a systematic binary interactome screen. The partners are unrelated to FAH's enzymatic function and are consistent with high-throughput screening artifacts. Retained but flagged as an over-annotation (not removed, as it is an experimental IPI) per the guideline discouraging bare protein binding.
|
|
GO:0006572
L-tyrosine catabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Ensembl-Compara ortholog-transfer IEA of tyrosine catabolic process from the mouse ortholog (P35505).
Reason: This transfers a correct annotation (L-tyrosine catabolic process) from the mouse ortholog Fah. It is redundant with the IBA and TAS annotations to the same term and is at the appropriate level of specificity, so it is accepted despite being an ortholog-transfer inference.
|
|
GO:0006559
L-phenylalanine catabolic process
|
IEA
GO_REF:0000041 |
ACCEPT |
Summary: UniPathway-derived electronic annotation to L-phenylalanine catabolic process (UniPathway UPA00139).
Reason: UniProt records FAH as step 6/6 of L-phenylalanine degradation to acetoacetate and fumarate (UPA00139/UER00341). This IEA correctly reflects that pathway placement and is consistent with the IBA to the same term.
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres... |
KEEP AS NON CORE |
Summary: High-throughput mass-spectrometry detection of FAH in prostatic-secretion (urinary) exosome preparations.
Reason: FAH was cataloged among ~900 proteins in a shotgun proteomic survey of urinary exosomes. This is a bulk proteomics detection rather than a functional localization; FAH is fundamentally a cytosolic liver/kidney enzyme. The annotation is retained as a non-core secondary location observation.
Supporting Evidence:
PMID:23533145
In pooled EPS-urine exosome samples, ~900 proteins were detected.
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:19056867 Large-scale proteomics and phosphoproteomics of urinary exos... |
KEEP AS NON CORE |
Summary: High-throughput mass-spectrometry detection of FAH in human urinary exosome proteome.
Reason: FAH was among 1132 proteins identified in a large-scale proteomic profile of human urinary exosomes. As with PMID:23533145, this is a proteomic catalog detection, not a functional site of action; kept as non-core relative to the core cytosolic localization.
Supporting Evidence:
PMID:19056867
the analysis identified 1132 proteins unambiguously
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-71181 |
ACCEPT |
Summary: Traceable assertion (Reactome) that FAH acts in the cytosol, where the final step of tyrosine degradation occurs.
Reason: FAH is a cytosolic enzyme catalyzing the terminal cytosolic step of tyrosine/phenylalanine catabolism. This is the core subcellular localization and is well established.
Supporting Evidence:
Reactome:R-HSA-71181
This is the final step of tyrosine degradation.
|
|
GO:0004334
fumarylacetoacetase activity
|
TAS
PMID:1998338 Cloning and expression of the cDNA encoding human fumarylace... |
ACCEPT |
Summary: Traceable assertion of fumarylacetoacetase activity from the human FAH cDNA cloning and expression study, which demonstrated hydrolysis of the natural substrate.
Reason: Expression of the human FAH cDNA yielded a protein with fumarylacetoacetase enzymatic activity, directly supporting the core molecular function annotation.
Supporting Evidence:
PMID:1998338
having enzymatic activity as shown by the hydrolysis of the natural substrate fumarylacetoacetate
|
|
GO:0006572
L-tyrosine catabolic process
|
TAS
PMID:9305902 Complete rescue of lethal albino c14CoS mice by null mutatio... |
ACCEPT |
Summary: Traceable assertion that FAH is the last enzyme of the tyrosine catabolic pathway, based on the Fah-deficient mouse model of tyrosinemia type 1.
Reason: This annotation is directly supported: FAH encodes the last enzyme in tyrosine catabolism, and its loss causes accumulation of toxic pathway intermediates. Core biological process.
Supporting Evidence:
PMID:9305902
HT1 is due to mutations in the fumarylacetoacetate hydrolase gene Fah, encoding the last enzyme in the tyrosine catabolic pathway.
|
FAH catalyzes the fifth and final step of the cytosolic L-tyrosine (and L-phenylalanine)
catabolic pathway: hydrolysis of 4-fumarylacetoacetate to fumarate + acetoacetate.
PMID:1998338 β TAS annotation to GO:0004334 (PINC). This is the human FAH cloning/expression paper; abstract-only cache but establishes human FAH catalyzes the FAA hydrolysis reaction and that the in vivo dimer is a homodimer.
Homogentisate (2,5-dihydroxyphenylacetate) is the intermediate produced by HPD from
4-hydroxyphenylpyruvate and consumed by HGD in the tyrosine pathway, upstream of FAH.
FAH acts on 4-fumarylacetoacetate, three steps downstream of homogentisate, so it is part
of the same overall pathway but does not itself catabolize homogentisate. The IBA is a
pathway-level (whole-pathway) grouping propagated across the FAH family; keep as non-core
(over-broad relative to FAH's actual biochemical step).
FAH deficiency causes hepatorenal tyrosinemia type I (TYRSN1, MIM:276700), the most severe
tyrosinemia [UniProt DISEASE]. Loss of the terminal step causes accumulation of upstream
toxic intermediates fumarylacetoacetate (FAA) and maleylacetoacetate (MAA), and the derived
metabolite succinylacetone (SA). FAA triggers hepatocyte apoptosis via mitochondrial
cytochrome c release; SA inhibits ALA dehydratase (porphyria-like crises). Leads to hepatic
necrosis/cirrhosis, hepatocellular carcinoma risk, and renal tubular dysfunction. Treated
with nitisinone (NTBC, an HPD inhibitor blocking the pathway upstream) plus Tyr/Phe-restricted
diet.
- dismech Tyrosinemia_Type_I.yaml: "FAH deficiency leads to accumulation of toxic intermediates including fumarylacetoacetate (FAA), maleylacetoacetate (MAA), and succinylacetone (SA). FAA directly injures hepatocytes through mitochondrial cytochrome c release with caspase-mediated apoptosis."
- Apoptosis mechanism PMID:9305902
- Many disease-causing loss-of-activity missense variants documented (e.g. N16I, A134D, C193R, D233V, W234G, R381G) [UniProt VARIANT features].
id: P16930
gene_symbol: FAH
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
FAH encodes fumarylacetoacetase (fumarylacetoacetate hydrolase, EC 3.7.1.2), the enzyme
that catalyzes the fifth and final step of the cytosolic L-tyrosine and L-phenylalanine
catabolic pathway: the hydrolysis of 4-fumarylacetoacetate to fumarate plus acetoacetate.
It is a homodimer, with each subunit using a bound Ca(2+) and Mg(2+) ion as catalytic
cofactors, and is expressed mainly in liver and kidney with lower levels in other tissues.
By clearing 4-fumarylacetoacetate, FAH prevents accumulation of this reactive intermediate
and the upstream metabolite maleylacetoacetate, feeding fumarate into the citric acid cycle
and acetoacetate into ketone-body/lipid metabolism. Loss-of-function variants cause
hepatorenal tyrosinemia type I (TYRSN1), the most severe tyrosinemia, in which accumulated
fumarylacetoacetate, maleylacetoacetate, and the derived toxin succinylacetone drive
hepatocyte apoptosis, cirrhosis, hepatocellular carcinoma risk, and renal tubular
dysfunction.
alternative_products:
- name: '1'
id: P16930-1
- name: '2'
id: P16930-2
sequence_note: VSP_055491
existing_annotations:
- term:
id: GO:0006572
label: L-tyrosine catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred involvement of FAH in L-tyrosine catabolism. FAH is the
terminal (fifth) enzyme of the tyrosine degradation pathway, and this is a core
biological-process annotation.
action: ACCEPT
reason: >-
FAH catalyzes the last step of tyrosine catabolism, hydrolyzing 4-fumarylacetoacetate
to fumarate and acetoacetate; this is well supported experimentally and is the defining
role of the gene. The IBA is consistent with the whole FAH family and with the direct
human evidence.
supported_by:
- reference_id: PMID:9305902
supporting_text: >-
HT1 is due to mutations in the fumarylacetoacetate hydrolase gene Fah, encoding the
last enzyme in the tyrosine catabolic pathway.
- term:
id: GO:0004334
label: fumarylacetoacetase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetically inferred fumarylacetoacetase (EC 3.7.1.2) activity. This is the
core molecular function of FAH.
action: ACCEPT
reason: >-
Direct enzymatic activity is documented for human FAH and the term matches the
catalyzed reaction exactly (4-fumarylacetoacetate + H2O = acetoacetate + fumarate + H+).
The IBA is at the correct level of specificity.
supported_by:
- reference_id: PMID:1998338
supporting_text: >-
having enzymatic activity as shown by the hydrolysis of the natural substrate
fumarylacetoacetate
- term:
id: GO:0006559
label: L-phenylalanine catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred involvement in L-phenylalanine catabolism. Phenylalanine is
catabolized via conversion to tyrosine, so FAH is the terminal step of both pathways.
action: ACCEPT
reason: >-
UniProt places FAH as the final step (step 6/6) of L-phenylalanine degradation to
acetoacetate and fumarate (UniPathway UPA00139). The annotation is correct, though the
phenylalanine framing is one metabolic conversion removed from FAH's direct substrate;
the more direct role is captured by L-tyrosine catabolic process.
supported_by:
- reference_id: PMID:1998338
supporting_text: >-
having enzymatic activity as shown by the hydrolysis of the natural substrate
fumarylacetoacetate
- term:
id: GO:1902000
label: homogentisate catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred involvement in homogentisate catabolism. Homogentisate is a
tyrosine-pathway intermediate several steps upstream of FAH's substrate.
action: KEEP_AS_NON_CORE
reason: >-
FAH acts on 4-fumarylacetoacetate, three enzymatic steps downstream of homogentisate
(which is ring-cleaved by HGD to maleylacetoacetate). This IBA reflects a pathway-level
grouping propagated across the FAH family rather than a direct role of FAH in
homogentisate breakdown. It is not wrong at the whole-pathway level but is broader than
FAH's actual biochemical step, so it is retained as non-core.
- term:
id: GO:0003824
label: catalytic activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro2GO electronic annotation to the root molecular-function catalytic term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
GO:0003824 is the top-level catalytic activity term and is uninformative for FAH, whose
specific activity (fumarylacetoacetase, GO:0004334) is already annotated with stronger
evidence. It is not incorrect, but it is an over-general mapping superseded by the
specific EC 3.7.1.2 term.
- term:
id: GO:0004334
label: fumarylacetoacetase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic annotation (combined IEA pipeline, keyed to RHEA:10244 / EC 3.7.1.2) to the
core fumarylacetoacetase activity term.
action: ACCEPT
reason: >-
This IEA maps FAH to its correct catalyzed reaction via RHEA:10244 and EC 3.7.1.2, in
agreement with the IBA and TAS annotations to the same term. Redundant but correct.
- term:
id: GO:0009072
label: aromatic amino acid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro2GO electronic annotation to the broad aromatic amino acid metabolic process
grouping term.
action: KEEP_AS_NON_CORE
reason: >-
Tyrosine and phenylalanine are aromatic amino acids, so FAH's catabolic role legitimately
falls under this grouping term. However it is more general than the specific tyrosine and
phenylalanine catabolic process annotations that better describe FAH, so it is retained
as non-core.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: >-
Bare protein binding from a high-throughput binary interactome (Y2H) screen; interactors
include TCF4 and keratin-associated proteins.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This is an uninformative bare protein binding annotation from a genome-scale binary
interactome map (the human interactome network / HuRI project). The reported partners
(e.g. TCF4, keratin-associated proteins) have no plausible functional relationship to a
cytosolic tyrosine-catabolic hydrolase and are typical high-throughput Y2H hits. Per
curation guidelines this bare protein binding conveys no specific molecular function; it
is retained but flagged as an over-annotation (not removed, as it is an experimental IPI).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Bare protein binding from the HuRI binary reference interactome (Y2H); interactors
include ADAMTSL4, CHRDL2, KRTAP13-3, PLEKHF2, SERTAD1.
action: MARK_AS_OVER_ANNOTATED
reason: >-
As with PMID:25416956, this is an uninformative bare protein binding annotation from a
systematic binary interactome screen. The partners are unrelated to FAH's enzymatic
function and are consistent with high-throughput screening artifacts. Retained but flagged
as an over-annotation (not removed, as it is an experimental IPI) per the guideline
discouraging bare protein binding.
- term:
id: GO:0006572
label: L-tyrosine catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Ensembl-Compara ortholog-transfer IEA of tyrosine catabolic process from the mouse
ortholog (P35505).
action: ACCEPT
reason: >-
This transfers a correct annotation (L-tyrosine catabolic process) from the mouse
ortholog Fah. It is redundant with the IBA and TAS annotations to the same term and is
at the appropriate level of specificity, so it is accepted despite being an
ortholog-transfer inference.
- term:
id: GO:0006559
label: L-phenylalanine catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: >-
UniPathway-derived electronic annotation to L-phenylalanine catabolic process
(UniPathway UPA00139).
action: ACCEPT
reason: >-
UniProt records FAH as step 6/6 of L-phenylalanine degradation to acetoacetate and
fumarate (UPA00139/UER00341). This IEA correctly reflects that pathway placement and is
consistent with the IBA to the same term.
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:23533145
qualifier: located_in
review:
summary: >-
High-throughput mass-spectrometry detection of FAH in prostatic-secretion (urinary)
exosome preparations.
action: KEEP_AS_NON_CORE
reason: >-
FAH was cataloged among ~900 proteins in a shotgun proteomic survey of urinary exosomes.
This is a bulk proteomics detection rather than a functional localization; FAH is
fundamentally a cytosolic liver/kidney enzyme. The annotation is retained as a non-core
secondary location observation.
supported_by:
- reference_id: PMID:23533145
supporting_text: >-
In pooled EPS-urine exosome samples, ~900 proteins were detected.
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:19056867
qualifier: located_in
review:
summary: >-
High-throughput mass-spectrometry detection of FAH in human urinary exosome proteome.
action: KEEP_AS_NON_CORE
reason: >-
FAH was among 1132 proteins identified in a large-scale proteomic profile of human
urinary exosomes. As with PMID:23533145, this is a proteomic catalog detection, not a
functional site of action; kept as non-core relative to the core cytosolic localization.
supported_by:
- reference_id: PMID:19056867
supporting_text: >-
the analysis identified 1132 proteins unambiguously
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-71181
qualifier: located_in
review:
summary: >-
Traceable assertion (Reactome) that FAH acts in the cytosol, where the final step of
tyrosine degradation occurs.
action: ACCEPT
reason: >-
FAH is a cytosolic enzyme catalyzing the terminal cytosolic step of tyrosine/phenylalanine
catabolism. This is the core subcellular localization and is well established.
supported_by:
- reference_id: Reactome:R-HSA-71181
supporting_text: This is the final step of tyrosine degradation.
- term:
id: GO:0004334
label: fumarylacetoacetase activity
evidence_type: TAS
original_reference_id: PMID:1998338
qualifier: enables
review:
summary: >-
Traceable assertion of fumarylacetoacetase activity from the human FAH cDNA cloning and
expression study, which demonstrated hydrolysis of the natural substrate.
action: ACCEPT
reason: >-
Expression of the human FAH cDNA yielded a protein with fumarylacetoacetase enzymatic
activity, directly supporting the core molecular function annotation.
supported_by:
- reference_id: PMID:1998338
supporting_text: >-
having enzymatic activity as shown by the hydrolysis of the natural substrate
fumarylacetoacetate
- term:
id: GO:0006572
label: L-tyrosine catabolic process
evidence_type: TAS
original_reference_id: PMID:9305902
qualifier: involved_in
review:
summary: >-
Traceable assertion that FAH is the last enzyme of the tyrosine catabolic pathway,
based on the Fah-deficient mouse model of tyrosinemia type 1.
action: ACCEPT
reason: >-
This annotation is directly supported: FAH encodes the last enzyme in tyrosine
catabolism, and its loss causes accumulation of toxic pathway intermediates. Core
biological process.
supported_by:
- reference_id: PMID:9305902
supporting_text: >-
HT1 is due to mutations in the fumarylacetoacetate hydrolase gene Fah, encoding the
last enzyme in the tyrosine catabolic pathway.
core_functions:
- description: >-
Fumarylacetoacetase catalyzing the terminal step of cytosolic tyrosine/phenylalanine
catabolism: hydrolysis of 4-fumarylacetoacetate to fumarate and acetoacetate.
molecular_function:
id: GO:0004334
label: fumarylacetoacetase activity
directly_involved_in:
- id: GO:0006572
label: L-tyrosine catabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:1998338
supporting_text: >-
having enzymatic activity as shown by the hydrolysis of the natural substrate
fumarylacetoacetate
- reference_id: PMID:9305902
supporting_text: >-
HT1 is due to mutations in the fumarylacetoacetate hydrolase gene Fah, encoding the
last enzyme in the tyrosine catabolic pathway.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to orthologs
using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:19056867
title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
findings:
- statement: >-
FAH was among 1132 proteins identified in a large-scale proteomic profile of human
urinary exosomes; a bulk proteomics detection rather than a functional localization.
supporting_text: >-
the analysis identified 1132 proteins unambiguously
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Abstract-verified. Supports HDA extracellular-exosome detection of FAH but is a
proteomic catalog, not evidence of functional localization for a cytosolic enzyme.
- id: PMID:1998338
title: 'Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase,
the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome
15.'
findings:
- statement: >-
Human FAH cDNA expressed in mammalian cells produces an enzymatically active protein
that hydrolyzes the natural substrate fumarylacetoacetate; the in vivo dimer is a
homodimer.
supporting_text: >-
having enzymatic activity as shown by the hydrolysis of the natural substrate
fumarylacetoacetate
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-verified; establishes human FAH catalyzes the fumarylacetoacetate hydrolysis
reaction (core MF) and maps the gene to chromosome 15q23-q25.
- id: PMID:23533145
title: In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions
in urine.
findings:
- statement: >-
FAH was cataloged among ~900 proteins in a shotgun proteomic survey of prostatic-secretion
(urinary) exosomes.
supporting_text: >-
In pooled EPS-urine exosome samples, ~900 proteins were detected.
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Abstract-verified. Bulk exosome proteomics; supports HDA extracellular-exosome
detection but not a core functional localization.
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings:
- statement: >-
Genome-scale binary interactome (Y2H) map reporting FAH interactions with partners
unrelated to its enzymatic function.
supporting_text: A proteome-scale map of the human interactome network.
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Correctly cited high-throughput binary interactome screen. Yields only uninformative
bare protein binding with functionally unrelated partners; annotation recommended for
removal.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings:
- statement: >-
HuRI binary reference interactome (Y2H) reporting FAH interactions with functionally
unrelated partners (e.g. ADAMTSL4, CHRDL2, KRTAPs, PLEKHF2, SERTAD1).
supporting_text: A reference map of the human binary protein interactome.
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Correctly cited systematic binary interactome map; only supports bare protein binding
with unrelated partners, recommended for removal.
- id: PMID:9305902
title: Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate
dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval
of the tyrosine catabolic pathway.
findings:
- statement: >-
Fah encodes the last enzyme of the tyrosine catabolic pathway; its loss causes
accumulation of fumarylacetoacetate, maleylacetoacetate, and succinylacetone that
trigger hepatocyte apoptosis, the mouse model of tyrosinemia type 1.
supporting_text: >-
HT1 is due to mutations in the fumarylacetoacetate hydrolase gene Fah, encoding the
last enzyme in the tyrosine catabolic pathway.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-verified. Establishes FAH's pathway position (terminal tyrosine-catabolic
enzyme) and the toxic-metabolite/apoptosis mechanism of tyrosinemia type 1.
- id: Reactome:R-HSA-71181
title: FAH cleaves 4FAA
findings:
- statement: >-
Reactome reaction: FAH (a cytosolic homodimer using Ca2+ and Mg2+ cofactors) catalyzes
the final step of tyrosine degradation, hydrolyzing 4-fumarylacetoacetate to fumarate
and acetoacetate.
supporting_text: This is the final step of tyrosine degradation.
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Cached Reactome entry describing the FAH-catalyzed terminal reaction and cytosolic
localization; consistent with UniProt catalytic/cofactor/subunit annotations.